New meta-analysis below [1].
I have a number of posts on abnormal coagulation & the need to monitor with D-dimer tests - & the use of nattokinase to speed clot elimination. Currently, doctors wait until cancer patients get a DVT or pulmonary embolism, etc. Those who do not die on the way to the ER are then put on anticoagulants.
In other words, there are no prophylactic meds, so docs do not screen for patients at risk - or even look for active clots.
"Incidental pulmonary embolism (IPE) is a common finding on computed tomography (CT). IPE is frequent in oncologic patients undergoing staging CT."
You can't really ignore a pulmonary embolism when it is accidentally found.
"The overall frequency of {incidental pulmonary embolism} in oncologic patients was 3.36%" However, "The highest frequency was found in prostate cancer (8.59% ...)" Wow!
"The highest frequency of IPE {incidental pulmonary embolism} was identified in prostate cancer patients. It has been shown previously that patients with prostate cancer are at higher risk of thromboembolic diseases, with the highest risk for those receiving endocrine therapy. Moreover, it was stated that prostate cancer itself, prostate cancer treatments, and selection mechanisms all contribute to an increased risk of thromboembolic events. Beyond that, the high frequency of IPE in the present study might be caused by the fact that prostate cancer staging CTs are mainly performed at the metastasized tumor stage compared to other tumor entities, which harbors in itself a higher risk of IPE."
As I say, a D-dimer test may identify a growing clot. If the number is zero, there is no clot. D-dimer may be elevated for other reasons, but where there is high risk of a clot, one should consider taking nattokinase. In my opinion. I'm not a doctor, etc, etc."
-Patrick